However Cologuard has been productive, there are challenges with Precise Sciences that buyers won't be able to forget. Very first, the corporate's leading-line advancement fee has long been decreasing. In the first quarter, Correct Sciences' income of $638 million greater by slightly below six% calendar year around calendar year.certified din plus